Breaking News Instant updates and real-time market news.

AIV

Aimco

$43.82

1.01 (2.36%)

, BXP

Boston Properties

$129.12

0.2 (0.16%)

08:32
08/06/18
08/06
08:32
08/06/18
08:32

BMO to hold a tour

L.A. Property Tour will travel throughout Los Angeles, CA visiting various companies on August 6.

AIV

Aimco

$43.82

1.01 (2.36%)

BXP

Boston Properties

$129.12

0.2 (0.16%)

DEI

Douglas Emmett

$39.46

0.24 (0.61%)

JLL

Jones Lang LaSalle

$168.47

1.07 (0.64%)

KRC

Kilroy Realty

$73.58

0.58 (0.79%)

MAC

Macerich

$60.50

0.61 (1.02%)

PLD

Prologis

$66.80

0.93 (1.41%)

TCO

Taubman Centers

$63.43

0.77 (1.23%)

  • 06

    Aug

  • 08

    Aug

AIV Aimco
$43.82

1.01 (2.36%)

02/09/18
ZELM
02/09/18
UPGRADE
ZELM
Hold
Aimco upgraded to Hold from Sell at Zelman
03/02/18
BMOC
03/02/18
UPGRADE
BMOC
Market Perform
Aimco upgraded to Market Perform from Underperform at BMO Capital
03/02/18
BMOC
03/02/18
UPGRADE
Target $42
BMOC
Market Perform
Aimco upgraded to Market Perform at BMO Capital
As reported earlier, BMO Capital analyst John Kim upgraded Aimco to Market Perform from Underperform with a $42 price target. Kim states that while the REIT trades at a premium AFFO multiple, its NAV valuation discount of 16% is "too steep" considering its portfolio's "high quality".
05/10/18
ZELM
05/10/18
DOWNGRADE
ZELM
Sell
Aimco downgraded to Sell from Hold at Zelman
Zelman downgraded Aimco to Sell saying valuation misprices risks.
BXP Boston Properties
$129.12

0.2 (0.16%)

03/05/18
EVER
03/05/18
UPGRADE
EVER
Outperform
Boston Properties upgraded to Outperform from In Line at Evercore ISI
02/15/18
BOFA
02/15/18
UPGRADE
Target $145
BOFA
Buy
Boston Properties upgraded to Buy at BofA/Merrill
As previously reported, BofA/Merrill upgraded Boston Properties to Buy from Neutral and raised tis price target to $145 from $140, the highest on the Street. Analyst Jeffrey Spector expects outperformance to be driven by leasing progress in New York City and San Francisco, development leasing and starts, and above-average 2019 growth. Spector sees limited 2018-2019 earnings risk from rising rates given limited floating rate exposure and notes most markets are healthy.
02/15/18
BOFA
02/15/18
UPGRADE
BOFA
Buy
Boston Properties upgraded to Buy from Neutral at BofA/Merrill
02/05/18
02/05/18
UPGRADE

Buy
Boston Properties upgraded to Buy on re-leasing, pipeline at Edward Jones
As previously reported, Edward Jones analyst Mat Kopsky upgraded Boston Properties to Buy from Hold, citing the company's significant progress in re-leasing key properties and its "strong" development pipeline.
DEI Douglas Emmett
$39.46

0.24 (0.61%)

09/08/17
JANY
09/08/17
INITIATION
JANY
Neutral
Douglas Emmett initiated with a Neutral at Janney Capital
06/18/18
MZHO
06/18/18
UPGRADE
Target $44
MZHO
Buy
Douglas Emmett upgraded to Buy from Neutral at Mizuho
Mizuho analyst Richard Anderson upgraded Douglas Emmett to Buy and raised his price target for the shares to $44 from $39. The stock is down over 5% year-to-date, underperforming California-focused office real estate investment trusts, Anderson tells investors in a research note. The analyst views the valuation "disconnect" as overdone given Douglas Emmett's potential for both near- and longer-term growth.
JLL Jones Lang LaSalle
$168.47

1.07 (0.64%)

02/12/18
WEDB
02/12/18
NO CHANGE
Target $158
WEDB
Neutral
Jones Lang LaSalle price target raised to $158 from $136 at Wedbush
Wedbush analyst Jason Weaver raised his price target for Jones Lang LaSalle to $158 from $136 after a "strong" FY17 finish and as he believes it may be turning the corner on profitability. The analyst reiterates a Neutral rating on the shares.
04/03/18
GSCO
04/03/18
INITIATION
GSCO
Neutral
Jones Lang LaSalle initiated with a Neutral at Goldman Sachs
Goldman analyst Andrew Rosivach initiated Jones Lang LaSalle with a Neutral and $176 price target due to "extended" valuation.
04/03/18
04/03/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. LogMeln (LOGM) initiated with a Buy at Mizuho. 2. Jones Lang LaSalle (JLL) initiated with a Neutral at Goldman Sachs. 3. Spotify (SPOT) initiated with a Buy at Guggenheim. 4. USA Technologies (USAT) initiated with a Buy at Lake Street. 5. Stryker (SYK) initiated with an In Line at Evercore ISI. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/16/18
LEHM
05/16/18
NO CHANGE
Target $184
LEHM
Overweight
Jones Lang LaSalle target raised to $184 after management meetings at Barclays
After hosting management for investor meetings, Barclays analyst Ross Smotrich raised his price target for Jones Lang LaSalle to $184 from $179 and reiterates an Overweight rating on the shares. The analyst believes that the company should continue to benefit from its global scale, an "ever-expanding" suite of services and a growing proportion of recurring/non-transactional revenue. He sees "ample revenue opportunity" for Jones Lang LaSalle with existing clients.
KRC Kilroy Realty
$73.58

0.58 (0.79%)

12/15/17
JPMS
12/15/17
DOWNGRADE
Target $79
JPMS
Neutral
Kilroy Realty downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Anthony Paolone downgraded Kilroy Realty to Neutral with an unchanged price target of $79 in conjunction with his 2018 REIT outlook.
01/08/18
BARD
01/08/18
DOWNGRADE
BARD
Neutral
Kilroy Realty downgraded to Neutral from Outperform at Baird
02/27/18
SBSH
02/27/18
UPGRADE
Target $77
SBSH
Buy
Kilroy Realty upgraded to Buy from Neutral at Citi
Citi analyst Emmanuel Korchman upgraded Kilroy Realty to Buy and raised his price target for the shares to $77 from $74.
02/27/18
SBSH
02/27/18
UPGRADE
Target $77
SBSH
Buy
Kilroy Realty upgraded to Buy on valuation discount at Citi
Citi analyst Michael Bilerman upgraded Kilroy Realty to Buy from Neutral saying the stock could outperform given the valuation discount and the company's long-term development pipeline growth. The analyst raised his price target for shares to $77 from $74.
MAC Macerich
$60.50

0.61 (1.02%)

04/20/18
BMOC
04/20/18
UPGRADE
Target $66
BMOC
Outperform
Macerich upgraded to Outperform at BMO Capital on 'discount' valuation
As reported earlier, BMO Capital analyst R. Jeremy Metz upgraded Macerich to Outperform from Market Perform and raised his price target $66 from $62, saying the departure of long-time CEO Art Coppola "clears a significant roadblock" amid activist involvement and discount valuation. Metz adds there is potential for an "inflection" in fundamentals in FY18/19 and accelerating in same-store net operating income from more long-term oriented decisions by mall tenants that could lead to recovery in the stock price. The analyst contends that Macerich has "one of the most desirable US mall portfolio".
04/20/18
KEYB
04/20/18
NO CHANGE
Target $75
KEYB
Overweight
Macerich CEO retirement may be viewed as catalyst for transaction, says KeyBanc
KeyBanc analyst Todd Thomas said yesterday's announcement that Art Coppola will retire from his position as chairman and CEO of Macerich on December 31 is "surprising," and comes at a time when two activist investors have reportedly staked interests in the company. Thomas, who has an Overweight rating and $75 price target on shares, thinks Coppola's retirement may be viewed as a potential catalyst for a transaction to materialize, and sees shares outperforming on the announcement.
04/20/18
04/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Buy from Neutral at MKM Partners with analyst Rob Sanderson telling investors that the service is "here to stay," citing its rebounding user growth and continued turnaround progress. 2. Macerich (MAC) upgraded to Outperform from Market Perform at BMO Capital and to Buy from Neutral at Mizuho. 3. Home Bancshares (HOMB) upgraded to Buy from Hold at Sandler O'Neill and to Outperform from Market Perform at Fig Partners. 4. UGI Corporation (UGI) upgraded to Buy from Neutral at UBS with analyst Shneur Gershuni saying the company offers above average earnings growth potential and strong financial metrics. 5. Darden (DRI) upgraded to Outperform from Market Perform at Bernstein. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/17/18
GSCO
07/17/18
UPGRADE
Target $60
GSCO
Neutral
Macerich upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Caitlin Burrows upgraded Macerich to Neutral and raised her price target for the shares to $60 from $52.
PLD Prologis
$66.80

0.93 (1.41%)

05/14/18
05/14/18
DOWNGRADE

Market Perform
DCT Industrial downgraded to Market Perform at Wells Fargo
As previously reported, Wells Fargo analyst Blaine Heck downgraded DCT Industrial (DCT) to Market Perform from Outperform, while raising his price target on the shares to $67 from $65, given the company's expected acquisition by Prologis (PLD).
04/30/18
JMPS
04/30/18
NO CHANGE
JMPS
Market Perform
Other bidders unlikely for DCT Industrial, says JMP Securities
After DCT Industrial (DCT) announced an agreement to be acquired by Prologis (PLD) in a stock-for-stock transaction valued at $8.4B, including debt, JMP Securities analyst Mitch Germain said he does not expect another bidder to emerge given the "full" pricing for the deal. He does, however, anticipate the potential for additional sector M&A activity, citing the pricing dynamic between public and private real estate, record levels of private equity dry powder on the sidelines and "readily available" debt financing. Germain has a Market Perform rating on DCT Industrial shares.
04/30/18
JEFF
04/30/18
NO CHANGE
Target $57
JEFF
Hold
Prologis paid a steep price for DCT Industrial, says Jefferies
Prologis (PLD) is paying a steep price to acquire DCT Industrial's (DCT) high-quality U.S. warehouse portfolio, but management expects 6c-8c of accretion after $80M of cost synergies, Jefferies analyst Jonathan Peters tells investors in a research note. At first glance, the cost synergy estimates appear aggressive, the analyst adds. He believes, however, that the combination of the well-located portfolios should drive solid organic revenue growth.
04/30/18
KEYB
04/30/18
NO CHANGE
KEYB
Prologis acquisition of DCT Industrial an affirmation of infill strategy, says KeyBanc
KeyBanc analyst Craig Mailman notes that Prologis (PLD) announced plans to acquire DCT (DCT) for $8.4B in a stock for stock deal at a 4.3% going-in cap rate. The analyst views the transaction as an affirmation of the infill strategy, as DCT represents the next best domestic platform among the larger industrial REIT portfolios.
TCO Taubman Centers
$63.43

0.77 (1.23%)

12/13/17
BMOC
12/13/17
UPGRADE
BMOC
Market Perform
Taubman Centers upgraded to Market Perform from Underperform at BMO Capital
12/13/17
BMOC
12/13/17
UPGRADE
Target $60
BMOC
Market Perform
Taubman Centers upgraded to Market Perform at BMO Capital on M&A activity
As noted earlier, BMO Capital analyst R. Jeremy Metz upgraded Taubman Centers to Market Perform from Underperform and raised his price target to $60 from $48. Metz says M&A activity, activist involvement, and speculation will keep shares supported in the near-term despite the challenging environment. The analyst cites the recent 3.8% position by Elliott Management as well as the acquisition of U.K. mall operator Westfield by Unibail-Rodamco.
12/13/17
12/13/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Huntsman (HUN) reinstated with an Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying a strengthened balance sheet from asset sales, "healthy" Urethane Chemical business conditions and good free cash flow generation bring a favorable risk/reward. 2. Dentsply Sirona (XRAY) upgraded to Overweight from Neutral at JPMorgan with analyst Tycho Peterson saying he expects "meaningful improvement" to the company's organic growth in 2018, although he notes management's initial guidance will likely be conservative. 3. O'Reilly Automotive (ORLY) upgraded to Outperform from Sector Perform at RBC Capital with analyst Scot Ciccarelli saying that despite the 15% run-up in stock price last month, 2018 set-up remains favorable with building demand from mild weather, easing comps headwinds, and an attractive relative valuation. 4. Extra Space Storage (EXR) upgraded to Equal Weight at Morgan Stanley with analyst Richard Hill saying he expects relatively less deceleration of core growth in the fourth quarter and for its 2018 guidance to be in line with expectations. He raised his price target on Extra Space Storage to $83 from $70. 5. Taubman Centers (TCO) upgraded to Market Perform from Underperform at BMO Capital with analyst R. Jeremy Metz saying M&A activity, activist involvement, and speculation will keep shares supported in the near-term despite the challenging environment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/15/18
JPMS
06/15/18
UPGRADE
Target $65
JPMS
Overweight
Taubman Centers upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Anthony Paolone upgraded Taubman Centers to Overweight with an unchanged price target of $65. The analyst views the stock as "cheap" and expects the company's NOI to ramp over the next couple of years as recent developments mature.

TODAY'S FREE FLY STORIES

IFF

International Flavors

$122.54

-0.98 (-0.79%)

21:34
03/20/19
03/20
21:34
03/20/19
21:34
Upgrade
International Flavors rating change at Goldman Sachs »

International Flavors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

QRVO

Qorvo

$69.15

-0.93 (-1.33%)

21:34
03/20/19
03/20
21:34
03/20/19
21:34
Upgrade
Qorvo rating change at Goldman Sachs »

Qorvo upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

ATI

Allegheny Technologies

$26.02

0.065 (0.25%)

21:34
03/20/19
03/20
21:34
03/20/19
21:34
Upgrade
Allegheny Technologies rating change at Goldman Sachs »

Allegheny Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INAP

Internap

$4.98

0.17 (3.53%)

21:33
03/20/19
03/20
21:33
03/20/19
21:33
Upgrade
Internap rating change at Wells Fargo »

Internap upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$108.62

-1.79 (-1.62%)

, CAG

Conagra Brands

$22.91

0.095 (0.42%)

20:25
03/20/19
03/20
20:25
03/20/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

DRI

Darden

$108.62

-1.79 (-1.62%)

CAG

Conagra Brands

$22.91

0.095 (0.42%)

CMC

Commercial Metals

$16.06

-0.06 (-0.37%)

GIII

G-III Apparel

$35.09

-0.475 (-1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

HYMTF

Hyundai Motor

$0.00

(0.00%)

19:51
03/20/19
03/20
19:51
03/20/19
19:51
Periodicals
Hyundai shareholders to vote on Elliott Management dividend demand, Reuters says »

Hyundai Motor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVBF

CVB Financial

$21.12

-0.53 (-2.45%)

19:45
03/20/19
03/20
19:45
03/20/19
19:45
Hot Stocks
CVB Financial raises quarterly dividend to 18c from 14c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KAMN

Kaman

$57.84

0.345 (0.60%)

19:24
03/20/19
03/20
19:24
03/20/19
19:24
Periodicals
Kaman exploring sale of distribution segment, Bloomberg says »

Kaman is looking into a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

VALE

Vale

$13.49

-0.21 (-1.53%)

19:19
03/20/19
03/20
19:19
03/20/19
19:19
Hot Stocks
Vale suspends operations at Alegria mine in Mariana complex on preventive basis »

Vale S.A. informs that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

EQH

AXA Equitable

$20.84

-0.565 (-2.64%)

19:12
03/20/19
03/20
19:12
03/20/19
19:12
Syndicate
AXA Equitable 40M share Secondary priced at $20.50 »

JPMorgan, Morgan Stanley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

OTTW

Ottawa Bancorp

$13.56

-0.14 (-1.02%)

19:02
03/20/19
03/20
19:02
03/20/19
19:02
Hot Stocks
Ottawa Bancorp declares special dividend of 35c per share »

The special dividend will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAZZ

Jazz Pharmaceuticals

$133.73

-1.74 (-1.28%)

18:57
03/20/19
03/20
18:57
03/20/19
18:57
Hot Stocks
Jazz Pharmaceuticals' Sunosi for excessive daytime sleepiness approved by FDA »

Jazz…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

AYI

Acuity Brands

$123.00

-5.53 (-4.30%)

18:52
03/20/19
03/20
18:52
03/20/19
18:52
Upgrade
Acuity Brands rating change at Goldman Sachs »

Acuity Brands upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Apr

HYAC

Haymaker Acquisition

$11.79

(0.00%)

, OSW

OneSpaWorld

$0.00

(0.00%)

18:47
03/20/19
03/20
18:47
03/20/19
18:47
Hot Stocks
OneSpaWorld says will start trading on Nasdaq March 21 »

OneSpaWorld Holdings…

HYAC

Haymaker Acquisition

$11.79

(0.00%)

OSW

OneSpaWorld

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

$35.07

-0.85 (-2.37%)

, MU

Micron

$40.08

-0.3 (-0.74%)

18:46
03/20/19
03/20
18:46
03/20/19
18:46
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

MLHR

Herman Miller

$35.07

-0.85 (-2.37%)

MU

Micron

$40.08

-0.3 (-0.74%)

WSM

Williams-Sonoma

$56.88

0.09 (0.16%)

SIEN

Sientra

$9.76

0.945 (10.73%)

EB

Eventbrite

$20.09

-0.72 (-3.46%)

GES

Guess

$22.10

-0.41 (-1.82%)

UNIT

Uniti Group

$10.01

0.15 (1.52%)

WEX

Wex

$184.85

-1.465 (-0.79%)

CBMG

Cellular Biomedicine

$18.26

0.38 (2.13%)

FTDR

Frontdoor

$32.10

-2.29 (-6.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 02

    Apr

  • 03

    Apr

  • 28

    May

  • 21

    Mar

  • 21

    Mar

SAGE

Sage Therapeutics

$152.62

-3.46 (-2.22%)

18:39
03/20/19
03/20
18:39
03/20/19
18:39
Hot Stocks
Sage Therapeutics CEO: Postpartum depression is a medical issue »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$174.38

-1.39 (-0.79%)

18:27
03/20/19
03/20
18:27
03/20/19
18:27
Recommendations
Nvidia analyst commentary at Tigress Financial »

Nvidia to overcome…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CURLF

Curaleaf Holdings

$0.00

(0.00%)

, CVS

CVS Health

$56.17

-0.93 (-1.63%)

18:24
03/20/19
03/20
18:24
03/20/19
18:24
Periodicals
CVS to start selling CBD products in partnership with Curaleaf, Bloomberg says »

Curaleaf (CURLF) said…

CURLF

Curaleaf Holdings

$0.00

(0.00%)

CVS

CVS Health

$56.17

-0.93 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

PETQ

PetIQ

$29.87

0.91 (3.14%)

18:23
03/20/19
03/20
18:23
03/20/19
18:23
Hot Stocks
PetIQ CEO: We are totally transparent about our price model »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

T

AT&T

$30.51

-0.19 (-0.62%)

18:21
03/20/19
03/20
18:21
03/20/19
18:21
Periodicals
AT&T CEO: Huawei makes it hard for carriers to shift suppliers, Reuters says »

AT&T CEO Randall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 24

    Apr

  • 26

    Apr

  • 07

    May

  • 20

    May

SGSOY

SGS SA

$0.00

(0.00%)

18:19
03/20/19
03/20
18:19
03/20/19
18:19
Downgrade
SGS SA rating change at Goldman Sachs »

SGS SA downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$155.94

-0.93 (-0.59%)

, RBGLY

Reckitt Benckiser

$0.00

(0.00%)

18:16
03/20/19
03/20
18:16
03/20/19
18:16
Hot Stocks
Clorox files false advertising lawsuit against Reckitt Benckiser »

The Clorox Company (CLX)…

CLX

Clorox

$155.94

-0.93 (-0.59%)

RBGLY

Reckitt Benckiser

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

BA

Boeing

$376.41

2.54 (0.68%)

18:09
03/20/19
03/20
18:09
03/20/19
18:09
Periodicals
Boeing pushes flight test to International Space Station to August, Reuters says »

Boeing has postponed by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

CE

Celanese

$101.04

0.08 (0.08%)

18:02
03/20/19
03/20
18:02
03/20/19
18:02
Hot Stocks
Celanese increases acetyl intermeditates prices »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

FTDR

Frontdoor

$32.10

-2.29 (-6.66%)

17:58
03/20/19
03/20
17:58
03/20/19
17:58
Syndicate
Frontdoor 16.73M share Secondary priced at $30.00 »

JPMorgan and Goldman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.